| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/25/2001 | EP0626863B1 Formulations containing hyaluronic acid |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/25/2001 | CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/25/2001 | CN1292292A Qixiao Kangyu pill made up by using several natural Chinese medicinal materials |
| 04/24/2001 | US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221889 Interleukin antagonist; skin disorders, respiratory system disorders, rheumatic disorders |
| 04/24/2001 | US6221887 Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221867 4,5-pyrazinoxindoles |
| 04/24/2001 | US6221856 Inositol derivatives for inhibiting superoxide anion production |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221377 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/24/2001 | CA2046397C Inflammatory bowel disease preventive and curative agents containing zinc l- carnosine salt or complex as active ingredient |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001027144A2 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 04/19/2001 | WO2001027114A1 PYRROLO[2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 04/19/2001 | WO2001027111A2 Bicyclic imidazo-3-yl-amine derivatives |
| 04/19/2001 | WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027098A2 Method for producing cox-2 inhibitors |
| 04/19/2001 | WO2001027097A1 Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
| 04/19/2001 | WO2001027096A1 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026676A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026658A2 Topical nasal treatment using desloratadine |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026653A1 V TYPE AND/OR X TYPE sPLA2 INHIBITORS |
| 04/19/2001 | WO2001026648A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 04/19/2001 | WO2001026637A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 04/19/2001 | WO2001026627A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000046198A8 Anti-inflammatory indole derivatives |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 04/19/2001 | WO1998008546A8 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2387145A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2385172A1 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2383970A1 Topical nasal treatment using desloratadine |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/19/2001 | CA2381297A1 Pyrrolo¬2,3-d|pyrimidine nucleoside analogs |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1092430A1 Non-chlorofluorocarbon aerosol formulations |
| 04/18/2001 | EP1092025A1 Human emr1-like g protein coupled receptor |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1091974A2 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091747A2 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions |
| 04/18/2001 | EP1091738A1 BICYCLIC sPLA 2 INHIBITORS |
| 04/18/2001 | EP1091737A2 Calcium channel blockers |
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0874815B1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 04/18/2001 | EP0731697B1 Ssi tyrphostins and pharmaceutical compositions |
| 04/18/2001 | EP0579827B1 Method of preparing 2-arylbenzimidazole 5-sulphonic acids |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1291981A Thiophene nitrone compounds |
| 04/18/2001 | CN1291980A thioether furan nitrone compounds |
| 04/18/2001 | CN1291979A Novel pyridazine derivatives and drugs containing same as active ingredient |
| 04/18/2001 | CN1291978A Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists |
| 04/18/2001 | CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system |
| 04/18/2001 | CN1291508A Injury-treating antalgic Chinese patent medicine |
| 04/18/2001 | CN1291483A Medicine for treating rheumatic and rheumatoid diseases |
| 04/18/2001 | CN1291476A Medicine for muscular fatigue |
| 04/18/2001 | CN1064533C Compound capsule for treating red swollen and heat evil duo to wind-cold-dampness |
| 04/17/2001 | US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds |
| 04/17/2001 | US6218419 Aminoiminoquinone and aminoquinone alkaloid compounds and methods of use |
| 04/17/2001 | US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies |